Phenotypic heterogeneity and evolution of melanoma cells associated with targeted therapy resistance

被引：0
|
作者：
Su, Yapeng [1 ,2 ]
Bintz, Marcus [3 ]
Yang, Yezi [3 ]
Robert, Lidia [4 ]
Ng, Alphonsus H. C. [1 ,2 ]
Liud, Victoria [2 ]
Ribas, Antoni [3 ,4 ,5 ,6 ]
Heath, James R. [1 ,2 ,6 ]
Wei, Wei [1 ,3 ,6 ]
机构：
[1] Institute for Systems Biology, Seattle,WA, United States
[2] Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena,CA, United States
[3] Department of Molecular and Medical Pharmacology, University of California – Los Angeles, Los Angeles,CA, United States
[4] Department of Medicine, University of California – Los Angeles, Los Angeles,CA, United States
[5] Department of Surgery, Division of Surgical-Oncology, University of California – Los Angeles, Los Angeles,CA, United States
[6] Jonsson Comprehensive Cancer Center, University of California – Los Angeles, Los Angeles,CA, United States
来源：
PLoS Computational Biology | 2019年 / 15卷 / 06期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Targeted Therapy in Melanoma
    Rokhzan, Ramin
    Meier, Katharina
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (24): : E66 - E66
  • [42] Targeted therapy in melanoma
    Tawbi, Hussein
    Nimmagadda, Neelima
    BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 475 - 484
  • [43] Targeted therapy of melanoma
    Blank, C.
    ONKOLOGIE, 2013, 36 : 220 - 220
  • [44] Targeted Therapy Of Lung Cancer: The Role Of Osteopontin For Cancer Evolution And Heterogeneity
    Shi, L.
    Chen, C.
    Wang, X.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [45] Phenotypic heterogeneity promotes adaptive evolution
    Bodi, Zoltan
    Farkas, Zoltan
    Nevozhay, Dmitry
    Kalapis, Dorottya
    Lazar, Viktoria
    Csorgo, Balint
    Nyerges, Akos
    Szamecz, Bela
    Fekete, Gergely
    Papp, Balazs
    Araujo, Hugo
    Oliveira, Jose L.
    Moura, Gabriela
    Santos, Manuel A. S.
    Szekely, Tamas, Jr.
    Balazsi, Gabor
    Pal, Csaba
    PLOS BIOLOGY, 2017, 15 (05)
  • [46] Targeted Elimination of the slowly proliferating Subpopulation of Tumor Cells to overcome the intrinsic Resistance to Therapy of malignant Melanoma
    Roesch, A.
    Vultur, A.
    Wang, H.
    Speicher, D.
    Bogeski, I
    Hoth, M.
    Gimotty, P.
    Villanueva, J.
    Fukunaga-Kalabis, M.
    Vogt, T.
    Herlyn, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 11 - 11
  • [47] Phenotypic heterogeneity guides adaptive evolution
    Farkas, Zoltan
    Bodi, Zoltan
    Nevozhay, Dmitry
    Kalapis, Dorottya
    Lazar, Viktoria
    Csoergo, Balint
    Nyerges, Akos
    Szamecz, Bela
    Araujo, Hugo
    Oliveira, Jose L.
    Moura, Gabriela R.
    Santos, Manuel A. S.
    Balazsi, Gabor
    Pal, Csaba
    YEAST, 2015, 32 : S103 - S103
  • [48] Phenotypic heterogeneity in modeling cancer evolution
    Mandipour-Shirayeh, Ali
    Kaveh, Kamran
    Kohandel, Mohammad
    Sivaloganathan, Sivabal
    PLOS ONE, 2017, 12 (10):
  • [49] MYC drives phenotypic heterogeneity, metastasis, and therapy resistance in pancreatic ductal adenocarcinoma
    English, Isabel A.
    Worth, Patrick J.
    Farrell, Amy S.
    Allen-Petersen, Brittany L.
    Shah, Vidhi
    Betts, Courtney
    Pelz, Carl
    Wang, Xiaoyan
    Daniel, Colin J.
    Thoma, Mary C.
    Coussens, Lisa M.
    Langer, Ellen M.
    Sears, Rosalie C.
    CANCER RESEARCH, 2022, 82 (12)
  • [50] Myc drives phenotypic heterogeneity, metastasis, and therapy resistance in pancreatic ductal adenocarcinoma
    English, Isabel A.
    Worth, Patrick J.
    Farrell, Amy S.
    Allen-Petersen, Brittany L.
    Shah, Vidhi
    Betts, Courtney
    Pelz, Carl
    Wang, Xiaoyan
    Daniel, Colin J.
    Thoma, Mary C.
    Coussens, Lisa M.
    Langer, Ellen M.
    Sears, Rosalie C.
    CANCER RESEARCH, 2022, 82 (22) : 46 - 47
12345